Electrical muscle controller
First Claim
Patent Images
1. A method of modifying an activity of a heart or of a portion thereof, the method comprising:
- applying to cardiac neural tissue which is nervous tissue contacting heart muscle an electric field of a magnitude, shape, duty cycle, phase, frequency, and duration suitable to obtain a desired change, to modify an activity of the heart or a portion thereof, wherein said field is applied at a time at which it is non-excitatory and thereof unable to generate a propagating action potential in the heart muscle, wherein said field has a strength insufficient for defibrillation the heart by synchronization of refractory and non-refractory cells to which it is applied and wherein said field is applied during an absolute refractory phase of cardiac muscle cells in tissue adjacent said cardiac neural tissue an in synchrony with activation thereof.
6 Assignments
0 Petitions
Accused Products
Abstract
A method of modifying the force of contraction of at least a portion of a heart chamber, including providing a subject having a heart, comprising at least a portion having an activation, and applying a non-excitatory electric field having a given duration, at a delay after the activation, to the portion, which causes the force of contraction to be increased by a least 5%.
403 Citations
33 Claims
-
1. A method of modifying an activity of a heart or of a portion thereof, the method comprising:
- applying to cardiac neural tissue which is nervous tissue contacting heart muscle an electric field of a magnitude, shape, duty cycle, phase, frequency, and duration suitable to obtain a desired change, to modify an activity of the heart or a portion thereof, wherein said field is applied at a time at which it is non-excitatory and thereof unable to generate a propagating action potential in the heart muscle, wherein said field has a strength insufficient for defibrillation the heart by synchronization of refractory and non-refractory cells to which it is applied and wherein said field is applied during an absolute refractory phase of cardiac muscle cells in tissue adjacent said cardiac neural tissue an in synchrony with activation thereof.
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33)
Specification